HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pulmonary revalvulation and rhythmologenic risks in patients with repaired tetralogy of Fallot].

Abstract
Tetralogy of Fallot is a frequent congenital heart disease that has been repaired since the mid-1950s. The follow-up after repair is good despite a persistent risk of sudden death. The risk factors in long-term follow-up are advanced age at repair, hemodynamic status of the right ventricle, QRS duration≥180ms, left ventricular dysfunction, and existence of sustained or not ventricular tachycardia. In the presence of significant pulmonary regurgitation, it is necessary to perform revalvulation either by classic surgery or cardiac catheterization. To correct the risk of ventricular arrhythmia, some have proposed radiofrequency ablation of critical isthmus, or cryo-application during surgery. However, the use of implantable cardioverter defibrillator is another therapeutic option that is more and more employed as secondary or primary prevention in patients at risk of sudden death.
AuthorsRosario Pilato, Dominique Lacroix, Olivia Domanski, François Godart
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 46 Issue 6 Pt 1 Pg. 586-593 (Jun 2017) ISSN: 2213-0276 [Electronic] France
Vernacular TitleRevalvulation pulmonaire et risque rythmique chez les patients opérés d’une tétralogie de Fallot.
PMID28583744 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2017 Elsevier Masson SAS. All rights reserved.
Topics
  • Age Factors
  • Cardiac Catheterization
  • Catheter Ablation
  • Cause of Death
  • Cryosurgery
  • Death, Sudden, Cardiac (etiology, prevention & control)
  • Defibrillators, Implantable
  • Humans
  • Postoperative Complications (etiology, physiopathology)
  • Risk Factors
  • Tachycardia, Ventricular (etiology, physiopathology, prevention & control)
  • Tetralogy of Fallot (physiopathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: